BridgeMD
New treatment option for Muscle Disuse
Official title Immune Cells During Disuse and Recovery
ClinicalTrials.gov ID: NCT04416191
What this study is testing
- What it's testing
- This is an interventional study enrolling healthy individuals aged 18-35 and 60-85 to understand the recovery of muscle health following a period of inactivity. The enrollment goal is 45 participants.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85. Healthy volunteers may be eligible.
You may be able to join if
- Age between 18-35 and 60-85 yrs
- Ability to sign informed consent
- Free-living, prior to admission
You likely can't join if
- History of cardiovascular disease (e.g., CHF, CAD, right-to-left shunt)
- History of endocrine or metabolic disease such as hypo/hyperthyroidism and diabetes
- History of kidney disease or failure
- Vascular disease
- Risk of DVT including family history of thrombophilia, DVT, pulmonary emboli, myeloproliferative diseases including polycythemia (Hb\>18 g/dL) or...
- Use of anticoagulant therapy (e.g., Coumadin, heparin)
See the full eligibility criteria
- Age between 18-35 and 60-85 yrs
- Ability to sign informed consent
- Free-living, prior to admission
- History of cardiovascular disease (e.g., CHF, CAD, right-to-left shunt)
- History of endocrine or metabolic disease such as hypo/hyperthyroidism and diabetes
- History of kidney disease or failure
- Vascular disease
- Risk of DVT including family history of thrombophilia, DVT, pulmonary emboli, myeloproliferative diseases including polycythemia (Hb\>18 g/dL) or thrombocytosis (platelets\>400x103/mL), and connective tissue diseases...
- Use of anticoagulant therapy (e.g., Coumadin, heparin)
- Elevated systolic pressure \>150 or a diastolic blood pressure \> 100
- Implanted electronic devices (e.g., pacemakers, electronic infusion pumps, stimulators)
- Cancer or history of successfully treated cancer (less than 1 year) other than basal cell carcinoma
- Currently on a weight-loss diet
- Chronic systemic corticosteroid use (≥ 2 weeks) within 4 weeks of enrollment and for study duration (intra-articular/topical/inhaled therapeutic or physiologic doses of corticosteroids are permitted)
- Androgens or growth hormone within 6 months of enrollment and for study duration (topical physiologic androgen replacement is permitted)
- History of stroke with motor disability
- A recent history (\<12 months) of GI bleed
- History of liver disease
- History of respiratory disease (acute upper respiratory infection, history of chronic lung disease)
- Pregnancy as determined by a pregnancy test
- Any staff members who report directly to an investigator or who report to someone who reports directly to an investigator.
- Any other condition or event considered exclusionary by the PI and faculty physician
The study team makes the final eligibility decision.
Where it's taking place
- Salt Lake City, Utah, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Salt Lake City, Utah, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.